Icaritin alleviates cerebral ischemia-reperfusion injury by reducing ferroptosis via inhibiting excessive mPTP opening

preprint OA: closed CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

The narrow therapeutic window of reperfusion therapy highlight the urgent need for novel neuroprotective strategies against ischemic stroke, wherein ferroptosis is a key contributor to neuronal death in the ischemic penumbra. This study demonstrates that icaritin (ICT) treatment significantly improved functional outcomes, reduced infarct size,and enhanced neuronal viability in middle cerebral artery occlusion (MCAO) rats and oxygen-glucose deprivation and reoxygenation (OGD/R) PC-12 cells. Transcriptomic and biochemical analyses confirmed that ICT’s neuroprotection was associated with the suppression of ferroptosis. Mechanistically, ICT inhibited pathological mitochondrial permeability transition pore (mPTP) opening, thereby preserving mitochondrial membrane potential and attenuating reactive oxygen species (ROS) production. This action was essential, as the protective effect was mimicked by cyclosporin A (CsA) and abolished by lonidamine (LND). Molecular docking revealed stable binding of ICT to voltage-dependent anion channel (VDAC) and cyclophilin D (CypD.) In conclusion, ICT confers neuroprotection by inhibiting mPTP excessive opening, which in turn blocks the downstream ferroptosis cascade. This work elucidates a detailed mechanism for ICT and validates the “mPTP-ferroptosis” axis as a promising therapeutic target for ischemic stroke.
Full text 2,854 characters · extracted from oa-doi-fallback · click to expand
This is a preprint and has not been peer reviewed. Data may be preliminary. Icaritin alleviates cerebral ischemia-reperfusion injury by reducing ferroptosis via inhibiting excessive mPTP opening Abstract The narrow therapeutic window of reperfusion therapy highlight the urgent need for novel neuroprotective strategies against ischemic stroke, wherein ferroptosis is a key contributor to neuronal death in the ischemic penumbra. This study demonstrates that icaritin (ICT) treatment significantly improved functional outcomes, reduced infarct size,and enhanced neuronal viability in middle cerebral artery occlusion (MCAO) rats and oxygen-glucose deprivation and reoxygenation (OGD/R) PC-12 cells. Transcriptomic and biochemical analyses confirmed that ICT’s neuroprotection was associated with the suppression of ferroptosis. Mechanistically, ICT inhibited pathological mitochondrial permeability transition pore (mPTP) opening, thereby preserving mitochondrial membrane potential and attenuating reactive oxygen species (ROS) production. This action was essential, as the protective effect was mimicked by cyclosporin A (CsA) and abolished by lonidamine (LND). Molecular docking revealed stable binding of ICT to voltage-dependent anion channel (VDAC) and cyclophilin D (CypD.) In conclusion, ICT confers neuroprotection by inhibiting mPTP excessive opening, which in turn blocks the downstream ferroptosis cascade. This work elucidates a detailed mechanism for ICT and validates the “mPTP-ferroptosis” axis as a promising therapeutic target for ischemic stroke. Supplementary Material File (figure1.tif) - Download - 5.44 MB File (figure10.tif) - Download - 1.75 MB File (figure2.tif) - Download - 771.64 KB File (figure3.tif) - Download - 2.91 MB File (figure4.tif) - Download - 2.26 MB File (figure5.tif) - Download - 1.30 MB File (figure6.tif) - Download - 1.05 MB File (figure7.tif) - Download - 2.33 MB File (figure8.tif) - Download - 1.42 MB File (figure9.tif) - Download - 3.96 MB File (manuscript.docx) - Download - 84.32 KB Information & Authors Information Version history Copyright This work is licensed under a Non Exclusive No Reuse License. Authors Metrics & Citations Metrics Article Usage 136views 63downloads Citations Download citation Tianlun Wang, Wenjing Dai, Yuanqi Yu, et al. Icaritin alleviates cerebral ischemia-reperfusion injury by reducing ferroptosis via inhibiting excessive mPTP opening. Authorea. 26 March 2026. DOI: https://doi.org/10.22541/au.177452353.30311359/v1 DOI: https://doi.org/10.22541/au.177452353.30311359/v1 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-4.0